Oncolytic Viruses: Therapeutics With an Identity Crisis

Oncolytic viruses (OV) are replicating viral therapeutics for the treatment of cancer and have been in laboratory development for about twenty years. Recently, the FDA approved Imlygic, a herpes virus based therapeutic for the treatment of melanoma and thus OVs have entered a new era where they are...

Descripción completa

Detalles Bibliográficos
Autores principales: Breitbach, Caroline J., Lichty, Brian D., Bell, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972563/
https://www.ncbi.nlm.nih.gov/pubmed/27407036
http://dx.doi.org/10.1016/j.ebiom.2016.06.046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972563/
https://www.ncbi.nlm.nih.gov/pubmed/27407036
http://dx.doi.org/10.1016/j.ebiom.2016.06.046

Ejemplares similares